«

»

Guidelines for pharmacological treatment of GERD

by Medical Staff Office on December 16, 2013

From Choosing Wisely®: For pharmacological treatment of patients with gastroesophageal reflux disease (GERD), the American Gastroenterological Association recommends that long-term acid suppression therapy (proton pump inhibitors or histamine2 receptor antagonists) should be titrated to the lowest effective dose needed to achieve therapeutic goals. The main identifiable risk associated with reducing or discontinuing acid suppression therapy is an increased symptom burden. It follows that the decision regarding the need for (and dosage of) maintenance therapy is driven by the impact of those residual symptoms on the patient’s quality of life rather than as a disease control measure. >>More

Leave a Reply

Your email address will not be published.